BUSINESS
How complete gets Godrej after buying out Raymond's? Whiff of scepticism in the air
The Street is sceptical about how soon Godrej can increase market penetration and drive growth in Raymond’s deodorants and sexual wellness products
BUSINESS
HUL marks steady end to FY23 but brokerages trim EPS estimates on Q4 miss
FMCG market (urban and rural) registered flat volume growth in the March quarter, as per Nielsen data
BUSINESS
HUL chief Sanjiv Mehta sees end to volatility in 4-5% volume growth for FMCG
For FY23, HUL's rural volumes declined 7 percent while in Q4 FY23, the fall was about 3 percent
BUSINESS
We didn't overpay for Raymond's FMCG business: GCPL vows to level off margins
Godrej Consumer is yet to announce how the acquisition will be funded. It roughly has Rs 2,000 crore of cash on books
BUSINESS
MC Exclusive: Godrej Consumer may acquire Raymond's consumer care biz for over Rs 1000 cr
Raymond Ltd holds over 47 percent in the consumer care business, which houses Park Avenue and KamaSutra brands and had annual sales of Rs 522 crore in last fiscal
BUSINESS
HUL likely to report 13% rise in Q4 net profit, volume growth seen at 5%
On the margin front, HUL's EBITDA margin is expected to decline marginally on a year-on-year basis due to higher advertisement spends
BUSINESS
NSE decides to retain demerged entity in index. Move offers a relief to Reliance
A demerged company will be retained in a Nifty index vis-a-vis the earlier practice of excluding it
BUSINESS
Crompton Greaves CE pins hope on Shantanu Khosla but investors bit worried
Khosla, who has been elevated from the rank of managing director to executive vice-chairman, will remain on the board till December 2025. He has been with the company for seven years now
BUSINESS
Transport services have picked up, mining still volatile, says Morgan Stanley Chief India Economist
In the last quarter, there was an improvement in the services sector, particularly transport services. This means road and rail activity has seen a pronounced uptick, Chachra said
BUSINESS
Nestle India stuns the Street but valuations may keep investors at bay
According to Nuvama Institutional Equities, Nestle India has marked a "fabulous start to the year". Motilal Oswal Financial Services calls it a "big beat in a challenging environment"
BUSINESS
The myth around summer stocks
Analysts believe Symphony has an edge over other consumer durable companies but the stock price does not reflect this
BUSINESS
Crompton Greaves Consumer Electricals' 12% fall after CEO resignation an overreaction, say analysts
The company has appointed Promeet Ghosh as the new managing director and chief executive officer in place of Mathew Job, who has resigned, for five years
BUSINESS
Nestle India Q1 Preview | Revenue, profit growth seen at 13%, but volumes impacted
Milk and milk products, which is the biggest contributor to the company’s topline, is expected to see moderate sales. Confectionary segment, on the other hand, will continue its strong momentum
BUSINESS
Tata Consumer Products Q4 Preview: Revenue to grow 11% led by India foods business
With the announcement of Q4 earnings, the Street will be eyeing any updates on the acquisitions front and new product launches. Management commentary on volumes and tea prices will be key monitorables
BUSINESS
Daily Voice | Earnings growth expectations for FY24 should be revised down, says UTI AMC fund manager
Amit Premchandani of UTI AMC is positive on healthcare sector given that healthcare expenditure to GDP for a country like India is still pretty low.
BUSINESS
Brightcom clarifies on promoter stake sale but lots of questions still unanswered
Promoter shareholding in Brightcom declined from 40.45 percent on March 31, 2014 to 13.96 percent on March 31, 2020. The company has issued a clarification to shareholders but is yet to reply to the SEBI notice, which questions the firm’s accounting practices
BUSINESS
RIL may record 17% growth in Q4 operating profit, single-digit rise in topline, bottomline
Analysts will watch out for more clarity on the Rs 75,000-crore investment in the new energy business, growth in retail store additions and pricing in the telecom business
BUSINESS
Smallcap IT firm Mastek zooms 7% on strong Q4 show driven by UK deals
Some of Mastek’s top deals in the quarter gone by were Biometric Resident Permit (BRP) services for immigrants into the UK and back-office transformation programme for local authority of London
BUSINESS
Mankind to be a Bharat-focused player in listed pharma space
Mankind Pharma has zero debt. Its cash and cash equivalent in the nine-month period ended December 2022 stood at Rs 293.4 crore
BUSINESS
Angel One spurts on 30% profit growth but slowing activation rate remains a concern
In Q4, Angel One's gross client acquisitions stood at 1.3 million, up 31 percent sequentially but down 12 percent YoY
BUSINESS
ITC tops Rs 400, analysts see 10% upside while investors eye Rs 500
ITC has gained 48 percent over the year, making it the best-performing Nifty50 stock. After hitting a low of 28 percent in June 2020, the company's operating margins steadily improved to 38 percent in the December quarter of FY23
BUSINESS
What makes the Q4 flop show a bigger pain for Infosys than for TCS?
Infosys won deals worth $2.1 billion in the fourth quarter, lower than $3.3 billion in Q3. Meanwhile, TCS’ deal wins remained strong at $10 billion
BUSINESS
New-age stocks’ valuations now sensible, says Nippon MF’s Sailesh Raj Bhan
They are off their sky-high valuations even if they are still not cheap, he says; is underweight on FMCG companies
BUSINESS
Why Mankind Pharma finds Dabur as its man to look up to when it comes to valuations
If one draws parallels to Dabur India, then Pudin Hara and Activ Antacid in digestives, Shilajit Gold in multivitamins and Gulabari brand in skincare go head-to-head with Mankind Pharma’s earlier mentioned products
